Literature DB >> 2983811

Nitroglycerine- and isoprenaline-induced vasodilatation: assessment from the actions of cyclic nucleotides.

T Itoh, Y Kanmura, H Kuriyama, T Sasaguri.   

Abstract

To investigate the vasodilator actions of nitroglycerine and isoprenaline, the effects of these agents, dibutyryl cyclic AMP (db cyclic AMP) and 8-bromo cyclic GMP (8-Br cyclic GMP) on intact muscle tissue, and cyclic AMP and cyclic GMP on skinned muscle of the rabbit mesenteric artery were investigated. In porcine coronary artery, nitroglycerine (greater than 0.1 microM) increased the production of cyclic GMP with no change in the amount of cyclic AMP, while isoprenaline (greater than 0.1 microM) significantly increased the production of cyclic AMP with no change in the amount of cyclic GMP. In the rabbit mesenteric artery, nitroglycerine or isoprenaline inhibited the tonic component of the 39 mM [K]o-induced contraction to a greater extent than the phasic component. Nitroglycerine and 8-Br cyclic GMP showed a stronger inhibitory action on the K-induced contraction than did isoprenaline and db cyclic AMP. The sources of Ca utilized for the generation of contraction by noradrenaline and caffeine were estimated to be the same as those determined from the amplitudes of contractions evoked in Ca-free solution by various concentrations of noradrenaline or caffeine. In intact muscle tissues, the effects of nitroglycerine or 8-Br cyclic GMP on the amount of Ca stored in cells were estimated from the caffeine-induced contraction in Ca-free solution. Both agents inhibited the contractions due to a reduction in the amount of Ca in the cells. When the effects of isoprenaline or db cyclic AMP were observed, both agents inhibited the caffeine-induced contraction but the accumulation of Ca into cells was greater than the control. In saponin skinned muscles, the pCa-tension relationship in the presence of cyclic AMP and cyclic AMP-dependent protein kinase (cyclic AMP-PK) shifted to the right and to a lower level in comparison with the control. Applications of cyclic GMP with cyclic GMP-dependent protein kinase (cyclic GMP PK) also inhibited the contraction induced by low concentrations of Ca. In skinned muscles, cyclic AMP exhibited dual actions on Ca store sites, i.e. in the presence of high concentrations of Ca or prolonged superfusion of Ca, cyclic AMP reduced the amount of Ca due to activation of the Ca-induced Ca release mechanism by excess accumulation of Ca. On the other hand, cyclic GMP consistently inhibited the amplitude of the caffeine-induced contraction due to a reduction in the amount of Ca in the store sites. 8 These results indicate that nitroglycerine and isoprenaline increase the amount of cyclic GMP and cyclic AMP, respectively. The main effect of cyclic GMP is activation of Ca extrusion, thus reducing the amount of Ca stored in the cell, while the main effect of cyclic AMP is to increase the amount of Ca stored in the cell. Both cyclic AMP with cyclic AMP-PK and cyclic GMP with cyclic GMP-PK inhibit the phosphorylation of myosin. Consequently both cyclic nucleotides reduce the free Ca in the myoplasm and promote relaxation, but by different mechanisms.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2983811      PMCID: PMC1987288          DOI: 10.1111/j.1476-5381.1985.tb12923.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  30 in total

1.  Calcium sequestration by subcellular fractions isolated from vascular smooth muscle: effect of cyclic nucleotides and prostaglandins.

Authors:  R C Webb; R C Bhalla
Journal:  J Mol Cell Cardiol       Date:  1976-02       Impact factor: 5.000

2.  Partial purification and properties of guanosine 3':5'-monophosphate-dependent protein kinase from pig lung.

Authors:  K Nakazawa; M Sano
Journal:  J Biol Chem       Date:  1975-09-25       Impact factor: 5.157

3.  Stimulation of microsomal calcium uptake and protein phosphorylation by adenosine cyclic 3', 5'-monophosphate in rat uterus.

Authors:  K Nishikori; T Takenaka; H Maeno
Journal:  Mol Pharmacol       Date:  1977-07       Impact factor: 4.436

4.  Sodium nitroprusside and other smooth muscle-relaxants increase cyclic GMP levels in rat ductus deferens.

Authors:  K Schultz; K Schultz; G Schultz
Journal:  Nature       Date:  1977-02-24       Impact factor: 49.962

5.  Phosphodiesterase protein activator mimics red blood cell cytoplasmic activator of (Ca2+-Mg2+)ATPase.

Authors:  R M Gopinath; F F Vincenzi
Journal:  Biochem Biophys Res Commun       Date:  1977-08-22       Impact factor: 3.575

6.  Role of cyclic AMP in rat aortic microsomal phosphorylation and calcium uptake.

Authors:  R C Bhalla; R C Webb; D Singh; T Brock
Journal:  Am J Physiol       Date:  1978-05

7.  Ca++-binding properties of cznine aortic microsomes: lack of effect of c-AMP.

Authors:  J C Allen
Journal:  Blood Vessels       Date:  1977-03

8.  An ultrasensitive method for the simultaneous determination of cyclic AMP and cyclic GMP in small-volume samples from blood and tissue.

Authors:  M Honma; T Satoh; J Takezawa; M Ui
Journal:  Biochem Med       Date:  1977-12

9.  Effects of cAMP- and cGMP-dependent protein kinases, and calmodulin on Ca2+ uptake by highly purified sarcolemmal vesicles of vascular smooth muscle.

Authors:  E Suematsu; M Hirata; H Kuriyama
Journal:  Biochim Biophys Acta       Date:  1984-06-13

Review 10.  Cyclic nucleotides and smooth muscle.

Authors:  H P Bär
Journal:  Adv Cyclic Nucleotide Res       Date:  1974
View more
  25 in total

1.  Contribution of cyclic GMP formation to KRN2391-induced relaxation in coronary artery of the pig.

Authors:  Y Jinno; H Kasai; H Ohta; K Nishikori; H Fukushima; N Ogawa
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

2.  Vasodilating effects of human and rat calcitonin gene-related peptides in isolated porcine coronary arteries.

Authors:  T Shoji; H Ishihara; T Ishikawa; A Saito; K Goto
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-10       Impact factor: 3.000

3.  A phorbol ester has dual actions on the mechanical response in the rabbit mesenteric and porcine coronary arteries.

Authors:  T Itoh; Y Kanmura; H Kuriyama; K Sumimoto
Journal:  J Physiol       Date:  1986-06       Impact factor: 5.182

4.  Influence of the epithelium on responsiveness of guinea-pig isolated trachea to contractile and relaxant agonists.

Authors:  R G Goldie; J M Papadimitriou; J W Paterson; P J Rigby; H M Self; D Spina
Journal:  Br J Pharmacol       Date:  1986-01       Impact factor: 8.739

5.  Phospholamban is a good substrate for cyclic GMP-dependent protein kinase in vitro, but not in intact cardiac or smooth muscle.

Authors:  J P Huggins; E A Cook; J R Piggott; T J Mattinsley; P J England
Journal:  Biochem J       Date:  1989-06-15       Impact factor: 3.857

Review 6.  Ca2+ pumps in smooth muscle cells.

Authors:  L Raeymaekers; F Wuytack
Journal:  J Muscle Res Cell Motil       Date:  1993-04       Impact factor: 2.698

7.  Guanine nucleotide binding protein involved in muscarinic responses in the pig coronary artery is insensitive to islet-activating protein.

Authors:  T Sasaguri; M Hirata; T Itoh; T Koga; H Kuriyama
Journal:  Biochem J       Date:  1986-11-01       Impact factor: 3.857

8.  Effects of a water-soluble forskolin derivative (NKH477) and a membrane-permeable cyclic AMP analogue on noradrenaline-induced Ca2+ mobilization in smooth muscle of rabbit mesenteric artery.

Authors:  S Ito; S Suzuki; T Itoh
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

9.  Nitroglycerin relaxes canine coronary arterial smooth muscle without reducing intracellular Ca2+ concentrations measured with fura-2.

Authors:  T Yanagisawa; M Kawada; N Taira
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

10.  The relationship of KCl- and prostaglandin F2 alpha-mediated increases in tension of the porcine coronary artery with changes in intracellular Ca2+ measured with fura-2.

Authors:  J L Balwierczak
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.